Liuwei dihuang pill

1 paper3 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Animals1

Outcomes

Postmenopausal osteoporosis

downin mice1

1 study

Liuwei dihuang pill decreases postmenopausal osteoporosis in mice.
“LWDHW improves PMOP in mice by regulating osteoclast membrane fusion”
Animalsin PMOP micepill60 daysfemales
Liuwei Dihuang Pill regulate osteoclast membrane fusion to improve postmenopausal osteoporosis in mice: the CLCF1/NFATc1 signaling axis as a therapeutic target
Nan fang yi ke da xue xue bao = Journal of Southern Medical University11 Aug 2026

Latest

1 in 12 months

Nan Fang Yi Ke Da Xue Xue Bao11 Aug